Nuclear Medicine, Nuclear Cardiology · Eatontown, NJ
NPI
1093789612
Since 2006
Specialty
Nuclear Medicine, Nuclear Cardiology
Code 207UN0901X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
11 Meridian Rd
Eatontown, NJ, 07724
Phone (732) 663-0300
Groups this clinician bills Medicare through
Medicare paid, 2024
$552K
6,626 services
Medicare patients, 2024
1,917
Average age 77
Drug cost, 2024
$2.7M
15,454 prescriptions
Company payments, 2025
$135
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey Osofsky was code 99214 (office e&m - established), 2,510 times for 1,356 patients. In total Jeffrey Osofsky billed 6,626 services in 45 codes, and Medicare paid $552K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-03-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 2,510 | 1,356 | $95.39 | $239K |
| 93000 Electrocardiogram | Office | 878 | 822 | $10.18 | $8,936 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 749 | 188 | $5.36 | $4,018 |
| 93015 Electrocardiogram | Office | 343 | 339 | $53.59 | $18K |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 328 | 328 | $96.83 | $32K |
| 78452 Myocardial Perfusion Scan | Office | 326 | 326 | $380.96 | $124K |
| 93306 Echocardiography (TTE/TEE) | Office | 288 | 285 | $162.67 | $47K |
| 93010 Electrocardiogram | Facility | 229 | 201 | $6.81 | $1,559 |
| 99232 Hospital E&M - Subsequent | Facility | 172 | 131 | $66.27 | $11K |
| G0250 Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | Office | 151 | 19 | $7.37 | $1,112 |
| 99204 Office E&M - New | Office | 89 | 89 | $112.57 | $10K |
| 99233 Hospital E&M - Subsequent | Facility | 59 | 48 | $99.77 | $5,887 |
| 99222 Hospital E&M - Initial | Facility | 41 | 40 | $110.18 | $4,518 |
| 99211 Office E&M - Established | Office | 38 | 31 | $18.78 | $713 |
| 93224 Electrocardiogram | Office | 35 | 35 | $52.30 | $1,831 |
By year: 2022 $624K for 6,689 services; 2023 $575K for 6,322 services; 2024 $552K for 6,626 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey Osofsky prescribed most often to Medicare patients was Rosuvastatin Calcium, with 2,084 prescriptions and refills. In total Jeffrey Osofsky wrote 15,454 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 2,084 | 5,879 | 596 | $33K |
| Metoprolol Succinate Generic | 1,203 | 3,507 | 355 | $22K |
| Amlodipine Besylate Generic | 987 | 2,863 | 305 | $8,406 |
| Atorvastatin Calcium Generic | 874 | 2,529 | 254 | $9,887 |
| Ezetimibe Generic | 866 | 2,410 | 276 | $24K |
| Eliquis Apixaban | 793 | 1,653 | 182 | $933K |
| Furosemide Generic | 417 | 1,170 | 155 | $2,689 |
| Losartan Potassium Generic | 400 | 1,142 | 118 | $4,637 |
| Xarelto Rivaroxaban | 374 | 771 | 80 | $412K |
| Hydrochlorothiazide Generic | 353 | 1,032 | 120 | $2,261 |
| Carvedilol Generic | 345 | 904 | 94 | $3,996 |
| Valsartan Generic | 338 | 958 | 105 | $12K |
| Fenofibrate Generic | 326 | 912 | 93 | $11K |
| Olmesartan Medoxomil Generic | 275 | 766 | 84 | $7,043 |
| Lisinopril Generic | 233 | 694 | 76 | $2,093 |
Brand drugs: 2,301 claims; generic drugs: 13,153 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey Osofsky $135 ($135 in general payments such as food, travel and fees) from 5 companies. The largest payer was Amgen Inc. with $49.91.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.